Renin-angiotensin system component gene polymorphism in Japanese bronchial asthma patients

Journal of Asthma

Volumn 36, Issue 2, 1999, Pages 187-193

  Nakahama, Hajime ^a   Obata, Kyoko ^a   Nakajima, Taisuke ^a   Nakamura, Hitoshi ^a   Kitada, Osamu ^a   Sugita, Minoru ^a   Fujita, Yoshimasa ^c   Kawada, Noritaka ^b   Moriyama, Toshiki ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NONE

Author keywords

Ace I D polymorphism; Angiotensinogen T235 M235 polymorphism; Bronchial asthma

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 0032966549     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909909056316     Document Type: Article

References (38)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, de Zeeiw D: An insertion/deletion polymorphism in the angiotensin I-converting gene accounting for half the variance of serum enzyme levels. J Clin Invest 29:1343-1346 (1990).
2. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in the human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40 (1993).
3. Tiret L, Rigat B, Visvikise S, et al: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205 (1992).
4. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644 (1992).
5. Ohishi M, Fujii K, Minamino T, et al: A potent genetic risk factor for restenosis. Nat Genet 5:324-325 (1993).
6. Raynolds MV, Taft CS, Perryman BM: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 343:1073-1075 (1993).
7. Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638 (1994).
8. Yoshida H, Mitarai T, Kawamura T, et al: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169 (1995).
9. Moriyama T, Kitamura H, Ochi S, et al. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 6:1674-1678 (1995).
10. Caufield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Eng J Med 330:1629-1633 (1994).
11. Pei Y, Sholey J, Thai K, Suzuki M, Cattran D: Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 100:514-520 (1997).
12. Johnson AR, Shton J, Schulz WW, Erdos EG: Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 132:564-568 (1985).
13. Millar EA, Angus RM, Hulks G, et al: Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 49:492-495 (1994).
14. Tomaki M, Ichinose M, Miura M, et al: Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P. Thorax 51:199-201 (1996).
15. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-243 (1987).
16. Kawasaki ES: Sample preparation from blood, cells, and other fluids. In PCR Protocols. A Guide to Methods and Applications. (Michael A, Gelfand DH, Sninsky JJ, White TJ, editors). Academic Press Limited, San Diego, 1990, pp. 146-152.
17. Shanmugam V, Sell K, Saha B: Mistyping ACE heterozytes. PCR Meth Appl 3:120-121 (1993).
18. Ward K, Hara A, Jeunemaitre X, et al: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4:59-61 (1993).
19. Iwai N, Shimoike H, Ohmichi N, Kinoshita M: Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 25:688-693 (1995).
20. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K: Angiotensin converting enzyme as a generic risk factor for coronary artery spasm. J Clin Invest 96:2975-2979 (1995).
21. Yamakawa K, Kobayashi K, Arinami T, Hamaguchi H: Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 346:515 (1995).
22. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report, March 1993. National Institutes of Health, Bethesda, MD, 1995, pp. 58-59.
23. Postma DS, Bleecker ER, Amelung PJ, et al: Genetic susceptibility to asthma-bronchial hyperreponsiveness coinherited with a major gene for atopy. N Engl J Med 333:894-900 (1995).
24. Doull IJ, Lawrence S, Watson M, et al: Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 153:1280-1284 (1996).
25. Daniels SE, Bhattacharrya S, James A, et al: A genome-wide search for quantitative trait loci underlying asthma. Nature 383:247-250 (1996).
26. The Collaborative Study on the Genetics of Asthma: A genomewide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 15:389-392 (1997).
27. Shirakawa TS, Li A, Dubowitz M, et al: Association between atopy and variants of the b subunit of the high-affinity immunoglobulin E receptor. Nat Gen 7: 125-130 (1994).
28. Hall IP, Wheatley A, Wilding P, Liggett SB: Association of Glu 27 b2-adrenoreceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214 (1995).
29. Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA: The association of atopy with a gain-of-function mutation in the a subunit of the interleukin-4 receptor. N Engl J Med 337:1720-1725 (1997).
30. Furuya K, Yamaguchi E, Hirabayashi T, et al: Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet 343:354 (1994).
31. Morice AH, Turley AJ, Kinton K: Human ACE gene polymorphism and distilled water cough. Thorax 52: 111-113 (1997).
32. Benessiano J, Crestani B, Mestari F, et al: High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 99:53-57 (1997).
33. Furuya K, Yamaguchi E, Itoh A, et al: Deletion polymorphism in the angiotensin I-converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51:777-780 (1996).
34. Zee RY, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme with essential hypertension. Biochem Biophys Res Commun 184:9-15 (1992).
35. Bloem LJ, Manatunga AK, Boatright E, Pratt JH: Relation of race and a polymorphism in the angiotensin I-converting enzyme gene to enzyme levels (abstract). Hypertension 22:407 (1993).
36. Lee EJ: Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 37: 212-214 (1994).
37. Kamitani A, Rakugi H, Higaki J, et al: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 25:950-953 (1995).
38. Hata A, Namikawa C, Sasaki M: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285-1287 (1994).